Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choo, HYP | - |
dc.contributor.author | Choi, S | - |
dc.contributor.author | Jung, SH | - |
dc.contributor.author | Koh, HY | - |
dc.contributor.author | Pae, AN | - |
dc.date.accessioned | 2024-01-21T08:06:19Z | - |
dc.date.available | 2024-01-21T08:06:19Z | - |
dc.date.created | 2021-09-03 | - |
dc.date.issued | 2003-10-15 | - |
dc.identifier.issn | 0968-0896 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/138142 | - |
dc.description.abstract | Three-dimensional quantitative structure-activity relationship (3D-QSAR) studies for a series of arylsulfonylimidazolidinone derivatives having antitumor activity were conducted using comparative molecular field analysis (CoMFA) and comparative molecular similarity indices anaysis (CoMSIA). The in vitro cytotoxicity against human lung carcinoma (A549) exhibited a strong correlation with steric and electrostatic factors of the molecules. Four different types of models have been built using CoMFA and CoMSIA method with AM1 charge or Gasteiger-Huckel charge. By comparison of the statistical results of these models, model I obtained by CoMFA study with AM1 showed the best predictability of the antitumor activities based on the cross-validated value (0.642), conventional r(2) (0.981), standard error of estimate (0.106) and PRESS value (0.170). (C) 2003 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | CYTOTOXICITY | - |
dc.subject | 4-PHENYL-1-ARYLSULFONYLIMIDAZOLIDINONES | - |
dc.subject | REQUIREMENT | - |
dc.subject | 4-POSITION | - |
dc.title | The 3D-QSAR study of antitumor arylsulfonylimidazolidinone derivatives by CoMFA and CoMSIA | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/S0968-0896(03)00530-3 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY, v.11, no.21, pp.4585 - 4589 | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY | - |
dc.citation.volume | 11 | - |
dc.citation.number | 21 | - |
dc.citation.startPage | 4585 | - |
dc.citation.endPage | 4589 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000185877700007 | - |
dc.identifier.scopusid | 2-s2.0-0141615706 | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | CYTOTOXICITY | - |
dc.subject.keywordPlus | 4-PHENYL-1-ARYLSULFONYLIMIDAZOLIDINONES | - |
dc.subject.keywordPlus | REQUIREMENT | - |
dc.subject.keywordPlus | 4-POSITION | - |
dc.subject.keywordAuthor | 3D-QSAR | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.